Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04379284 · ClinicalTrials.gov registry record
Risks of COVID19 in the Pregnant Population
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 69
- Enrollment target
NCT04379284: Completed study, sponsored by Mayo Clinic.
NCT04379284 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 69 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04379284 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
Study Summary
It is unclear how COVID19 can be passed from mother to infant. The study investigators aim to collect maternal and neonatal samples from COVID19-infected pregnant women and compare them to pregnant women who have clinical indications for COVID 19 testing at the time of hospital admission but end up being COVID19 negative. Pregnant women who are either COVID19 positive or COVID19 negative with respiratory symptoms will be enrolled and followed during this study.
Interventions
- OTHER Biospecimen collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2020-05-08 |
| Est. Completion | 2021-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04379284
The ClinicalTrials.gov registry entry for NCT04379284 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biospecimen collection is the first listed.
NCT04379284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04379284 about?
NCT04379284 is a clinical study titled "Risks of COVID19 in the Pregnant Population". It is unclear how COVID19 can be passed from mother to infant. The study investigators aim to collect maternal and neonatal samples from COVID19-infected pregnant women and compare them to pregnant women who have clinical indications for COVID 19 testing at the time of hospital admission but end up ...
What is the current status of trial NCT04379284?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2020-05-08. Estimated completion is 2021-10-01.
What interventions are being tested in trial NCT04379284?
The interventions under investigation include: Biospecimen collection (OTHER).
Who is sponsoring clinical trial NCT04379284?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.